Cargando…

Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents

Hepatic hydrothorax (HH) is a transudative pleural effusion that complicates advanced liver cirrhosis. Cases refractory to medical treatment in the form of salt restriction and diuretics are labeled refractory hepatic hydrothorax (RHH) and may require transjugular intrahepatic portosystemic shunts (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussein, Maged H., Peedikayil, Musthafa Chalikandy, Zamir, Zamir Ahmed, Alfadda, Abdulrahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892087/ https://www.ncbi.nlm.nih.gov/pubmed/29675064 http://dx.doi.org/10.4103/atm.ATM_194_17

Ejemplares similares

Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis
por: Lee, Woo Jin, et al.
Publicado: (2011)

Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia
por: Al-Ashqar, Hamad Ibrahim, et al.
Publicado: (2013)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017)

Bi-directional hepatic hydrothorax
por: Nellaiyappan, Madhan, et al.
Publicado: (2017)

Hepatic hydrothorax without ascites as the first sign of liver cirrhosis
por: Kim, Jung Soo, et al.
Publicado: (2015)

Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax
por: Romero, Sarah, et al.
Publicado: (2022)

Direct intrahepatic portocaval shunt for refractory hepatic hydrothorax: a case report
por: Kawahara, Yo, et al.
Publicado: (2016)

Efficacy of nonsurgical tigecycline pleurodesis for the management of hepatic hydrothorax in patients with liver cirrhosis
por: Yilmaz, Nevin, et al.
Publicado: (2015)

Risk factors for hepatic hydrothorax in patients with cirrhosis: a clinical retrospective study
por: Bai, Xue, et al.
Publicado: (2023)

Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis
por: Hisanaga, Hiroshi, et al.
Publicado: (2022)

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials
por: Peedikayil, Musthafa Chalikandy, et al.
Publicado: (2014)

Primary biliary cirrhosis presenting with ascites and a hepatic hydrothorax: a case report
por: Wojcikiewicz, Thomas George, et al.
Publicado: (2009)

Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
por: Matei, Daniela, et al.
Publicado: (2021)

Inflammatory Fibroid Polyp of the Cecum can be Treated by Endoscopic Resection
por: Peedikayil, Musthafa Chalikandy, et al.
Publicado: (2008)

Acute Tension Hydrothorax in a Cirrhotic Patient With Hepatic Hydrothorax Without Ascites
por: Malangu, Boniface, et al.
Publicado: (2021)

Hepatic hydrothorax: An update and review of the literature
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2017)

Hepatic Hydrothorax: A Narrative Review
por: Pippard, Benjamin, et al.
Publicado: (2022)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Refractory Hepatic Hydrothorax: A Rare Complication of Systemic Sclerosis and Presinusoidal Portal Hypertension
por: Abrams, Gary A., et al.
Publicado: (2018)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
por: Zhang, Lin-Hao, et al.
Publicado: (2017)

Medical thoracoscopy for the treatment of complicated hepatic hydrothorax
por: Papakonstantinou, NA, et al.
Publicado: (2012)

Hepatic Hydrothorax without Any Evidence of Ascites
por: Doraiswamy, Vikram, et al.
Publicado: (2011)

Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients
por: Gou, Xiaoyuan, et al.
Publicado: (2022)

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021)

The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection
por: Freekh, Dalia A, et al.
Publicado: (2021)

The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
por: Ma, Bo, et al.
Publicado: (2022)

Surgical repair of hepatic hydrothorax caused by diaphragmatic fistula
por: Ikeda, Miho, et al.
Publicado: (2020)

Hepatic Hydrothorax in the Absence of Ascites: A Diagnostic Challenge
por: Kamath, Sangita, et al.
Publicado: (2021)

A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents
por: Nakamura, Atsushi, et al.
Publicado: (2021)

A case series: Egyptian experience in using chemical pleurodesis as an alternative management in refractory hepatic hydrothorax
por: Helmy, Nariman, et al.
Publicado: (2010)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis
por: Childs, Kate, et al.
Publicado: (2017)

Fetal primary hydrothorax with spontaneous resolution
por: Trocado, Vera, et al.
Publicado: (2017)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
por: Cacciola, Irene, et al.
Publicado: (2021)

Case Report: Indwelling Pleural Catheter Based Management of Refractory Hepatic Hydrothorax as a Bridge to Liver Transplantation
por: Selvan, Mayurun, et al.
Publicado: (2021)

Pneumothorax Ex-vacuo or “trapped lung” in the setting of hepatic hydrothorax
por: Kim, Yan S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rfccl9kulnml4c7bqap815eu7t